These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35862601)

  • 1. CE: Original Research: Cognitive Behavioral Therapy for Symptom Management in Treatment-Resistant Schizophrenia.
    Ryan M; Sattenspiel D; Chianese A; Rice H
    Am J Nurs; 2022 Aug; 122(8):24-33. PubMed ID: 35862601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive-behavioural therapy for clozapine-resistant schizophrenia: the FOCUS RCT.
    Morrison AP; Pyle M; Gumley A; Schwannauer M; Turkington D; MacLennan G; Norrie J; Hudson J; Bowe S; French P; Hutton P; Byrne R; Syrett S; Dudley R; McLeod HJ; Griffiths H; Barnes TR; Davies L; Shields G; Buck D; Tully S; Kingdon D
    Health Technol Assess; 2019 Feb; 23(7):1-144. PubMed ID: 30806619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CBTp for people with treatment refractory schizophrenia on clozapine: a systematic review and meta-analysis.
    Todorovic A; Lal S; Dark F; De Monte V; Kisely S; Siskind D
    J Ment Health; 2023 Feb; 32(1):321-328. PubMed ID: 33076721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive behavioural therapy in clozapine-resistant schizophrenia (FOCUS): an assessor-blinded, randomised controlled trial.
    Morrison AP; Pyle M; Gumley A; Schwannauer M; Turkington D; MacLennan G; Norrie J; Hudson J; Bowe SE; French P; Byrne R; Syrett S; Dudley R; McLeod HJ; Griffiths H; Barnes TRE; Davies L; Kingdon D;
    Lancet Psychiatry; 2018 Aug; 5(8):633-643. PubMed ID: 30001930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clozapine and paliperidone palmitate antipsychotic combination in treatment-resistant schizophrenia and other psychotic disorders: A retrospective 6-month mirror-image study.
    Bioque M; Parellada E; García-Rizo C; Amoretti S; Fortea A; Oriolo G; Palau P; Boix-Quintana E; Safont G; Bernardo M
    Eur Psychiatry; 2020 Jul; 63(1):e71. PubMed ID: 32669145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive Behavioural Therapy for Psychosis: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2018; 18(5):1-141. PubMed ID: 30443277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of Treatment-Resistant and Clozapine-Resistant Schizophrenia: A 12-Year Follow-up Study of First-Episode Schizophrenia-Spectrum Disorders.
    Chan SKW; Chan HYV; Honer WG; Bastiampillai T; Suen YN; Yeung WS; Lam M; Lee WK; Ng RMK; Hui CLM; Chang WC; Lee EHM; Chen EYH
    Schizophr Bull; 2021 Mar; 47(2):485-494. PubMed ID: 33043960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment resistant schizophrenia - review and a call to action.
    Lally J; Gaughran F
    Ir J Psychol Med; 2019 Dec; 36(4):279-291. PubMed ID: 30477599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive-behavioral therapy for schizophrenia: a review.
    Turkington D; Dudley R; Warman DM; Beck AT
    J Psychiatr Pract; 2004 Jan; 10(1):5-16. PubMed ID: 15334983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive behavioural therapy plus standard care versus standard care for people with schizophrenia.
    Jones C; Hacker D; Xia J; Meaden A; Irving CB; Zhao S; Chen J; Shi C
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD007964. PubMed ID: 30572373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New therapeutic approaches for treatment-resistant schizophrenia: a look to the future.
    Miyamoto S; Jarskog LF; Fleischhacker WW
    J Psychiatr Res; 2014 Nov; 58():1-6. PubMed ID: 25070124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Group cognitive behavioural therapy for psychosis in the Asian context: a review of the recent studies.
    Wong JPS; Ting KT; Wong AWS
    Int Rev Psychiatry; 2019; 31(5-6):460-470. PubMed ID: 31340692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcome of cognitive behaviour therapy clinical trials in central Scotland.
    Durham RC; Chambers JA; Power KG; Sharp DM; Macdonald RR; Major KA; Dow MG; Gumley AI
    Health Technol Assess; 2005 Nov; 9(42):1-174. PubMed ID: 16266559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between the examination rate of treatment-resistant schizophrenia and the clozapine prescription rate in a nationwide dissemination and implementation study.
    Yasui-Furukori N; Muraoka H; Hasegawa N; Ochi S; Numata S; Hori H; Hishimoto A; Onitsuka T; Ohi K; Hashimoto N; Nagasawa T; Takaesu Y; Inagaki T; Tagata H; Tsuboi T; Kubota C; Furihata R; Iga JI; Iida H; Miura K; Matsumoto J; Yamada H; Watanabe K; Inada K; Shimoda K; Hashimoto R
    Neuropsychopharmacol Rep; 2022 Mar; 42(1):3-9. PubMed ID: 34854260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient characteristics, burden and pharmacotherapy of treatment-resistant schizophrenia: results from a survey of 204 US psychiatrists.
    Correll CU; Brevig T; Brain C
    BMC Psychiatry; 2019 Nov; 19(1):362. PubMed ID: 31727015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment resistant schizophrenia: Clinical, biological, and therapeutic perspectives.
    Nucifora FC; Woznica E; Lee BJ; Cascella N; Sawa A
    Neurobiol Dis; 2019 Nov; 131():104257. PubMed ID: 30170114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rates of treatment-resistant schizophrenia from first-episode cohorts: systematic review and meta-analysis.
    Siskind D; Orr S; Sinha S; Yu O; Brijball B; Warren N; MacCabe JH; Smart SE; Kisely S
    Br J Psychiatry; 2022 Mar; 220(3):115-120. PubMed ID: 35049446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance is not futile: treatment-refractory schizophrenia - overview, evaluation and treatment.
    Faden J; Citrome L
    Expert Opin Pharmacother; 2019 Jan; 20(1):11-24. PubMed ID: 30407873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on novel antipsychotics and pharmacological strategies for treatment-resistant schizophrenia.
    de Bartolomeis A; Ciccarelli M; Vellucci L; Fornaro M; Iasevoli F; Barone A
    Expert Opin Pharmacother; 2022 Dec; 23(18):2035-2052. PubMed ID: 36368055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disorganization domain as a putative predictor of Treatment Resistant Schizophrenia (TRS) diagnosis: A machine learning approach.
    Barone A; De Prisco M; Altavilla B; Avagliano C; Balletta R; Buonaguro EF; Ciccarelli M; D'Ambrosio L; Giordano S; Latte G; Matrone M; Milandri F; Francesco DN; Vellucci L; de Bartolomeis A
    J Psychiatr Res; 2022 Nov; 155():572-578. PubMed ID: 36206601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.